title: [Influenza and pneumococcal immunization in cardiovascular prevention].
abstract: A group of interdisciplinary experts (cardiologists, clinicians, infectologists met with the purpose of analyzing the evidence revealed by the relationship between respiratory diseases caused by influenza, pneumococcal diseases and cardiovascular events, and the role played by immunization strategies applied in cardiovascular prevention. The present statement summarizes the conclusions reached by the expertise of the aforementioned professionals. Systematic revisions imply consistent evidence that influenza and pneumococcal infection lead to acute myocardial infarction and cardiovascular death. Studies published during the last 15 years suggest that vaccination against influenza and S. pneumoniae reduce the risk of acute coronary syndromes. With the current evidence, and considering cost-effectiveness, reducing operating expenses and safety profile of the vaccines, scientific societies, national and international government health agencies strongly recommend incorporating immunization programs in those patients with chronic cardiovascular disease.
authors.affiliation: Sanatorio Güemes, Hospital de Clínicas José de San Martín, Universidad de Buenos Aires, Argentina. E-mail: misosaliprandi@fsg.org.ar.
authors.forename: María Inés
authors.initials: MI
authors.lastname: Sosa Liprandi
authors.forename: Alvaro
authors.initials: A
authors.lastname: Sosa Liprandi
authors.forename: Alberto
authors.initials: A
authors.lastname: Fernández
authors.forename: Daniel
authors.initials: D
authors.lastname: Stecher
authors.forename: Pablo
authors.initials: P
authors.lastname: Bonvehí
authors.forename: María Teresa
authors.initials: MT
authors.lastname: Verón
mesh_terms: D054058:Acute Coronary Syndrome / Q000517:prevention & control*; D001118:Argentina; D002318:Cardiovascular Diseases / Q000517:prevention & control; D003362:Cost-Benefit Analysis; D006077:Government Agencies; D006801:Humans; D007114:Immunization / Q000191:economics; D007251:Influenza, Human / Q000517:prevention & control*; D009203:Myocardial Infarction / Q000517:prevention & control*; D011008:Pneumococcal Infections / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage*; D012196:Review Literature as Topic; D014611:Vaccination / Q000191:economics*
chemical_list: D022242:Pneumococcal Vaccines
keywords: acute myocardial infarction; cardiovascular prevention; influenza; pneumococcal pneumonia; vaccines